NK-derived exosomes in anti-tumor strategies

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Tumors pose significant challenges in research and treatment.
• Natural killer (NK) cells are key immune components in immunotherapy, capable of directly eliminating malignant cells.
• NK cell-derived exosomes (NK-Exos) possess inherent anti-tumor properties but face limitations like insufficient active components and poor targeting.

Purpose of the Study:

• To review recent advancements in NK-Exos-based anti-tumor strategies.
• To explore methods for enhancing the therapeutic efficacy of NK-Exos.
• To focus on native, drug-loaded, and surface-modified NK-Exos for tumor eradication.

Main Methods:

• Review of existing literature on NK cell-derived exosomes in cancer therapy.
• Analysis of strategies involving native exosomes, drug-loaded exosomes, and surface-modified exosomes.
• Examination of mechanisms of NK-Exos anti-tumor activity and limitations.

Main Results:

• NK-Exos utilize cytotoxic molecules, apoptosis induction, and cytokine secretion for anti-tumor effects.
• Unmodified NK-Exos exhibit limited therapeutic efficacy due to the tumor microenvironment and lack of specificity.
• Drug loading and surface engineering significantly enhance the anti-tumor potential of NK-Exos.

Conclusions:

• NK-Exos represent a promising cell-free immunotherapy for cancer.
• Drug loading and surface modification are crucial strategies to overcome the limitations of native NK-Exos.
• Engineered NK-Exos hold significant potential for effective tumor eradication.